The Defence Forces Memorial Hospital (DFMH) has successfully conducted its first red blood cell exchange procedure using the newly acquired Spectra Optia apheresis system, expanding the hospital’s capacity to provide specialised treatment for patients with complex blood disorders.

The procedure was carried out at the hospital’s Renal Unit on a 15-year-old patient living with sickle cell disease. The successful treatment demonstrates DFMH’s growing capacity to provide advanced care using modern medical technology and specialised healthcare skills.

Red blood cell exchange involves removing abnormal red blood cells from a patient and replacing them with healthy donor cells. For people living with sickle cell disease, the procedure helps reduce the level of sickled cells in the bloodstream and can lower the risk of serious complications.

The Spectra Optia system separates specific blood components during treatment while returning the required components to the patient. Its availability at DFMH means patients requiring specialised apheresis procedures can receive more of this care within the hospital, reducing the need for referrals to other health facilities.

The milestone reflects continued investment in modern medical equipment, specialised skills and improved patient care within Kenya’s military health system. The new capability also strengthens DFMH’s role as a specialised referral facility and expands access to advanced treatment for patients with blood disorders.